AgeneBio, Inc., is an emerging pharmaceutical company dedicated to developing innovative therapeutics that prevent neurodegeneration and preserve and restore cognitive function for unserved patients battling amnestic mild cognitive impairment (aMCI), the symptomatic pre-dementia stage of Alzheimer’s disease, and other neurological and psychiatric diseases. AgeneBio’s novel pipeline of therapies is based on decades of research at Johns Hopkins University and leading research centers worldwide showing that overactivity in the hippocampus contributes to cognitive impairment and drives neurodegeneration if not controlled. This overactivity is a characteristic feature of aMCI. If approved, AgeneBio’s Phase 3-ready lead candidate, AGB101, will be the first and only therapeutic targeting hippocampal overactivity and potentially the first therapeutic to slow progression to, and delay the onset of, Alzheimer’s dementia. AgeneBio also has a novel GABA-A alpha5 small molecule program in late discovery stage with therapeutic potential for a spectrum of untreated conditions including aMCI, autism and schizophrenia. Learn more at www.agenebio.com and follow us on Twitter @AgeneBio.
View Top Employees from AgeneBioWebsite | http://www.agenebio.com |
Revenue | $1 million |
Funding | $17.8 million |
Employees | 5 (1 on RocketReach) |
Founded | 2008 |
Address | 1101 E. 33rd Street Suite C310, Baltimore, Maryland 21218, US |
Phone | (410) 779-1260 |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Biotechnology, Pharmaceutical Development, Retail, Science and Engineering, Amnestic Mild Cognitive Impairment, Health Care, Neurodegeneration, Pharmaceutical, Alzheimer's dementia |
Web Rank | 29 Million |
Competitors | Acumen Pharmaceuticals, Inc., Brickell Biotech, Inc., Imago BioSciences, Inc., Leap Therapeutics, Neuren Pharmaceuticals |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular AgeneBio employee's phone or email?
The AgeneBio annual revenue was $1 million in 2024.
Michela Gallagher is the Founder of AgeneBio.
1 people are employed at AgeneBio.
AgeneBio is based in Baltimore, Maryland.
The NAICS codes for AgeneBio are [32, 325, 32541, 3254].
The SIC codes for AgeneBio are [28, 283].